Intellia Therapeutics Inc logo

Intellia Therapeutics Inc

FRA:38I (USA)  
€ 24.21 (-0.82%) Mar 27
At Loss
P/B:
2.39
Market Cap:
€ 2.40B ($ 2.58B)
Enterprise V:
€ 1.66B ($ 1.79B)
Volume:
5.00
Avg Vol (2M):
408.00
Also Trade In:
Market Cap € M 2,395.61
Enterprise Value € M 1,659.92
P/E(ttm) --
PE Ratio without NRI --
Forward PE Ratio --
Price/Book 2.39
Price/Sales 65.53
Price/Free Cash Flow --
Price/Owner Earnings --
Payout Ratio % --
Revenue (TTM) € M 33.00
EPS (TTM) € -5.02
Beneish M-Score 8.79
10-y EBITDA Growth Rate % --
5-y EBITDA Growth Rate % -28.30
y-y EBITDA Growth Rate % --
EV-to-EBIT -3.49
EV-to-EBITDA -3.55
PEG --
Shares Outstanding M 96.11
Net Margin (%) -1,326.51
Operating Margin % -1,420.51
Pre-tax Margin (%) -1,326.51
Quick Ratio 8.67
Current Ratio 8.67
ROA % (ttm) -35.35
ROE % (ttm) -42.82
ROIC % (ttm) -122.06
Dividend Yield % --
Altman Z-Score 4.04
Piotroski F-Score 3.00
Positive ROA N
Positive CFROA N
Higher ROA y-y Y
Cash flow > Earnings Y
Lower Leverage y-y Y
Higher Current Ratio y-y N
Less Shares Outstanding y-y N
Gross Margin Increase y-y N
Higher Asset Turnover y-y N

FRA:38I Number of Guru Trades

To

FRA:38I Volume of Guru Trades

To

Gurus Latest Trades with FRA:38I

No Available Data

FRA:38I is held by these investors

No Available Data